Clinical trial
Local Phase 4 Pan-European SMART Study
NCT00463866 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00463866 |
|---|---|
| Title | Local Phase 4 Pan-European SMART Study |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | Budesonide/formoterol |
| Enrollment | 8,424 |
| Start date | Mar 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Apr 20, 2007 |
| Last update posted | Mar 22, 2010 |
| Countries | Belgium, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Russia, Spain and 2 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: